John Hevizi Consultancy was established in February 2004 to provide focused and broad range support for activities in chemistry, manufacturing and controls in the periods leading up to and during phase I, phase II and phase III clinical development.

The emphasis is on sound technical input; experience based decision-making and the generation of quality data to deliver your CMC requirements on time, to support your analytical development and pharmaceutical development programs.

The Consultancy offers particular expertise in the area of pharmaceutical analysis, analytical methods, analytical validation, stability studies and quality control. However, the experience gained from heading the Pharmaceutical Development Group at a major Biotech company, allows the Consultancy to provide support across the whole range of CMC activities from API to the packaged clinical drug product supplies.

Since formation, the Consultancy has established professional working relationships with over 25 separate clients and these clients are based in the UK, mainland Europe, USA and Canada. These clients are predominately small virtual to medium sized pharmaceutical companies, with one or two exceptions.

If you require an independent pharmaceutical CMC consultant to advise, co-ordinate and manage your pharmaceutical analysis and pharmaceutical development programs, then John Hevizi Consultancy can make a significant contribution.

For full details of services available, please go to SERVICES.